CD47 and acute lymphoblastic leukemia: As a more direct approach to investigate the impact of both strategies on myeloid cell-mediated T-ALL killing, ADCP and ADCC experiments were performed with MOLT-13 cells, in which the CD47 or QPCTL genes were knocked-out by CRISPR/Cas technology.